News

All the latest developments
from the institute

2019 05 23 Queens Square

UCL research into genetic therapies for dementia boosted by £5m donation from The Sigrid Rausing Trust

A new programme to test promising genetic therapies for neurodegenerative and dementia-causing diseases such as Alzheimer’s will be launched at UCL thanks to a £5m donation by the Sigrid Rausing Trust, one of the UK’s largest philanthropic foundations.

Read Article
Dsc01148

UK DRI Early Career Workshop on neuroinflammation – An in-depth look at our first themed event

In the first focussed ‘Theme’ event for the UK DRI, early-career researchers from across the network joined together last month (10-11 April 19) to share knowledge and insight on the topic of neuroinflammation in a 2-day workshop

Read Article
Twitter In Stream Wide  Crete Conf Group 1

Meeting report: 'Development of the dopaminergic system – from stem cells to circuits'

Co-organised by Dr Emmanouil Metzakopian, UK DRI at Cambridge, the 2019 CamBioScience conference in Crete brought together researchers to discuss recent advances and future directions in fundamental and applied developmental neuroscience centred on the midbrain dopaminergic system.

Read Article
Mallucci Copy 3

UK DRI Associate Director partners with NHS Foundation Trust for new research in Cambridge

In Dementia Action Week, a unique research group, has been launched to test promising new drugs for dementia, including one of the world’s first studies with an antidepressant that could stop the disease progressing.

Read Article
Eisai Uk Dri Colab Image

Launching: £2m collaboration with Eisai to accelerate dementia research

This first-of-its-kind industry collaboration for the UK DRI aims to deliver innovative research that translates into improvements in diagnosis, treatment and prevention of all types of dementia.

Read Article
Academiatoindustry2

Recording: From Academia to Industry - A Lunchtime Conversation

Are you exploring a potential career move to industry? Watch two scientists talk about their career pathway, their transition from academia to industry, pros and cons, career tips…


Read Article
Dsc04978

UK DRI at Edinburgh Annual Symposium 2019

The 2nd Annual Symposium from the UK DRI at Edinburgh took place at the Royal Society on 30th April. PhD student Sophie Quick takes us through her highlights from the day.

Read Article
Busche

UK DRI Researcher receives prestigious Future Leaders Fellowship from UKRI

UK DRI fellow at UCL, Dr Marc Aurel Busche, has been named as a recipients of a new fellowship scheme run by UK Research and Innovation (UKRI).

Read Article
Image001

Promising Huntington’s drug trial results shared after over a decade’s work

The full results from a ground-breaking trial showing successful lowering of a toxic protein in the neurodegenerative condition Huntington’s Disease, have been published.

Read Article
De Strooper

Do ‘microglia’ hold the key to stop Alzheimer’s disease?

A research team led by Prof. Bart De Strooper, UK DRI Director, studied how specialised brain cells called microglia respond to the accumulation of toxic proteins in the brain, a feature typical of Alzheimer’s disease.

Read Article
Care Picture

Comment: New dementia classification highlights need for better diagnostics and personalised interventions

Scientists and clinicians have described a new form of dementia that exhibits symptoms similar to Alzheimer’s disease, and suggest 20% misdiagnosis in patients over 80 years old.

Read Article
Dementia Revolution Cheer Squad2

Running for the Dementia Revolution

This Sunday, thousands of marathon runners will be pounding the streets of London, raising vital money for charities across the UK. Many will be powering ground-breaking dementia research by fundraising for the UK Dementia Research Institute (UK DRI) through the Dementia Revolution campaign.

Read Article
Dsc04507

MP visit to UK DRI: Highlighting the importance of dementia research to the UK

We were delighted to welcome a group of MPs to the UK DRI labs at UCL today, to discuss the significant impact of dementia to our society and the ground-breaking research seeking to change that.

Read Article
Woman 3187087 1920

Study finds re-purposing blood pressure drug may treat several neurodegenerative conditions

A team led by Professor David Rubinsztein, UK DRI at Cambridge, have shown that a prescribed drug to treat high blood pressure may be effective in treating conditions such as Parkinson’s disease, Huntington’s disease and forms of dementia.

Read Article
Tech Monitor 2Mb

Launching: UK DRI Care Research & Technology at Imperial

We’re thrilled to officially appoint our seventh centre of the UK DRI, after a competitive search for a robust programme that asks new and fundamental questions on how to better support people with dementia.

Read Article
Thinkstock Photos 840358600

Dementia Ecosystem UK: ​Action through alliance

To tackle the challenge of dementias we must capitalise on the breadth of available resources and expertise, and build an integrated ecosystem. In this spirit, on 2 April 2019 the UK DRI hosted the first meeting with Directors of the UK major programmes.

Read Article
Dna 2331995 1280

Cells from Alzheimer’s disease patients shed light on disease mechanism

UK DRI researchers, together with leading colleagues in Alzheimer’s disease across UCL and beyond, have utilised patient-derived stem cells to uncover the effects of mutation on the processing of a key protein implicated in disease progression.

Read Article
Aruk2019 Crowd

Our highlights from the ARUK Conference 2019

Between 19-20th March, over 500 delegates came together in the small town of Harrogate in Yorkshire for the annual Alzheimer’s Research UK (ARUK) Conference – a particular highlight in the dementia meeting calendar.

Read Article
Medicine 1851178 1920

Disappointment as phase III aducanumab trials for Alzheimer’s disease stopped early

It was announced yesterday (Thursday 21st March) that pharmaceutical companies Biogen and Eisai are to discontinue two phase III trials of the Alzheimer’s disease drug aducanumab.

Read Article
Iimages Ap Princess Anne Visits Uk Dementia 014

The Princess Royal visits UK Dementia Research Institute at UCL

During the visit, The Princess met with our directors to hear about their vision for the institute, toured one of our new laboratories and learned about some of the cutting-edge research underway.

Read Article

Founding funders

Latest tweets from @UKDRI

RT @Debbie_abrahams: As co-chair of the APPG on Dementia, I am calling on the Government to increase its investment into dementia research,…
24 May 2019 15:57

RT @CPFT_Research: Helping discoveries benefit #NHS patients for #DAW2019 - @CPFT_NHS is working with @UKDRI @Cambridge_Uni on a pioneering…
24 May 2019 15:33